Procedure Volume Patient Data Patient Conditions Reviews Back to Top

Home > CA Providers > Internists & Internal Medicine Doctors

Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology

Accepting New Patients

(9 Ratings)

Specializes in: Internal Medicine (Adult Medicine), Oncology (Cancer Care) and Hematology (Blood Disorders)

Rosalind Franklin University of Medicine and Science, Chicago Medical School

Professional interests include: multiple myeloma, chronic lymphocytic leukemia (CLL)

400 PARNASSUS AVENUE FLOOR 4
SAN FRANCISCO, CA 94143

(415) 353-2051

Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology is an internist in SAN FRANCISCO, CA specializing in internal medicine (adult medicine), oncology (cancer care) and hematology (blood disorders). He graduated from Rosalind Franklin University of Medicine and Science, Chicago Medical School. Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology is affiliated with UCSF Health and UCSF.

Office Locations

400 PARNASSUS AVENUE FLOOR 4
SAN FRANCISCO, CA 94143

open_in_new

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

Volume of procedures performed by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology for Medicare patients.

doctor visit	57

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2013

The most common conditions of Medicare patients that Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology treated during 2013 were hypertension.

Hypertension	75
High Cholesterol	0
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2014

The most common conditions of Medicare patients that Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology treated during 2014 were hypertension.

Hypertension	75
High Cholesterol	0
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

Volume of procedures performed by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology for Medicare patients.

doctor visit	35

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology.

**Gender**
Male	28
Female	32

**Ethnicity**
Non-Hispanic White	32
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	26
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2015

The most common conditions of Medicare patients that Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology treated during 2015 were hypertension and high cholesterol.

Hypertension	53
High Cholesterol	37
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

Volume of procedures performed by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology for Medicare patients.

doctor visit	71

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology.

**Gender**
Male	15
Female	16

**Ethnicity**
Non-Hispanic White	18
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	0
From 75 to 84	12
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2016

The most common conditions of Medicare patients that Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology treated during 2016 were hypertension and chronic kidney disease.

Hypertension	45
High Cholesterol	0
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	35
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

Volume of procedures performed by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology for Medicare patients.

doctor visit	66

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology.

**Gender**
Male	11
Female	17

**Ethnicity**
Non-Hispanic White	16
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2017

The most common conditions of Medicare patients that Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology treated during 2017 were hypertension.

Hypertension	43
High Cholesterol	0
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

Volume of procedures performed by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology for Medicare patients.

doctor visit	66

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology.

**Ethnicity**
Non-Hispanic White	19
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	13
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2018

The most common conditions of Medicare patients that Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology treated during 2018 were hypertension and depression.

Hypertension	48
High Cholesterol	0
Stroke	0
Ischemic Heart Disease	0
Depression	35
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

Volume of procedures performed by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology for Medicare patients.

doctor visit	49

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology.

**Ethnicity**
Non-Hispanic White	18
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	16
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2019

The most common conditions of Medicare patients that Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology treated during 2019 were hypertension.

Hypertension	53
High Cholesterol	0
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

Volume of procedures performed by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology for Medicare patients.

doctor visit	74

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology.

**Gender**
Male	12
Female	20

**Ethnicity**
Non-Hispanic White	21
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	15
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2020

The most common conditions of Medicare patients that Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology treated during 2020 were hypertension, chronic kidney disease and high cholesterol.

Hypertension	56
High Cholesterol	41
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	41
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

Volume of procedures performed by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology for Medicare patients.

doctor visit	60

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology.

**Age**
From 65 to 74	13
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2021

The most common conditions of Medicare patients that Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology treated during 2021 were hypertension and chronic kidney disease.

Hypertension	50
High Cholesterol	0
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	43
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

Volume of procedures performed by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology for Medicare patients.

doctor visit	58

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology.

**Age**
From 65 to 74	11
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2022

The most common conditions of Medicare patients that Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology treated during 2022 were hypertension and high cholesterol.

Hypertension	61
High Cholesterol	57
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

Volume of procedures performed by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology for Medicare patients.

doctor visit	51

2023 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology.

**Gender**
Male	13
Female	17

**Age**
From 65 to 74	15
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2023

The most common conditions of Medicare patients that Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology treated during 2023 were high cholesterol and hypertension.

Hypertension	57
High Cholesterol	75
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2013 - 2023

Volume of procedures performed by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology for Medicare patients.

doctor visit	58

Average Medicare Patient Data From 2013 - 2023

Information about Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology.

**Gender**
Female	9
Male	7

**Ethnicity**
Black / African American	0
Asian / Pacific Islander	0
Non-Hispanic White	11
Native American / Alaskan Native	0
Hispanic	0
Other	0

**Age**
85 and over	0
75 to 84	1
Less than 65	0
65 to 74	9

Average of Total of Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology From 2013 - 2023

The highest averages of the most common conditions of Medicare patients that Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology treated were hypertension, high cholesterol, chronic kidney disease and depression.

Hypertension	56
High Cholesterol	19
Stroke	0
Ischemic Heart Disease	0
Depression	3
Chronic Kidney Disease	10
Asthma	0
Osteoporosis	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Atrial Fibrillation	0
Cancer	0
Dementia	0

Education & Training

Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology graduated from Rosalind Franklin University of Medicine and Science, Chicago Medical School. He completed residency at Mount Sinai School of Medicine Affiliated Hospitals. He is certified by the American Board of Internal Medicine, Medical Oncology and has a state license in New York.

Medical School: Rosalind Franklin University of Medicine and Science, Chicago Medical School

Residency: Mount Sinai School of Medicine Affiliated Hospitals (2009)

Board Certification: American Board of Internal Medicine, Medical Oncology

Licensed In: New York

Affiliations & Hospitals

Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology is associated with these hospitals and organizations:

UCSF Health

UCSF

Ratings & Reviews

Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology has an exceptional overall rating with an average of 4.98 out of 5 stars based on 9 ratings. We collect ratings and reviews of Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology from all over the web to help you find the right in SAN FRANCISCO, CA.

4.98

Overall Rating

(9 Ratings)

Leave a Review

Reviews From Around The Web

Overall Rating: 5.0 2025-02-08

Patient verified via Press Ganey

Dr Pourdehnad is knowledgeable, professional, and easy to talk to. He listens to questions and responds in easy to understand language.

Biography

Dr. Michael Pourdehnad's areas of specialization are oncology (cancer care) and hematology (blood disorders); he sees patients in San Francisco, CA. The average patient rating for Dr. Pourdehnad is 5.0 stars (out of 5). In his practice, Dr. Pourdehnad focuses on chronic lymphocytic leukemia (CLL) and multiple myeloma. He is professionally affiliated with UCSF Health. According to Doctor.com, he is currently accepting new patients at his office in SAN FRANCISCO, CA. He obtained his medical school training at Rosalind Franklin University of Medicine and Science, Chicago Medical School and performed his residency at a hospital affiliated with Mount Sinai School of Medicine.

Select Year:

Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology

Office Locations

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2013

Medicare Procedure and Patient Information

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2014

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

2015 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2015

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

2016 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2016

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

2017 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2017

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

2018 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2018

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

2019 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2019

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

2020 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2020

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

2021 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2021

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

2022 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2022

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

2023 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology in 2023

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2013 - 2023

Average Medicare Patient Data From 2013 - 2023

Average of Total of Conditions of Medicare patients treated by Dr. Michael Pourdehnad, MD, Hematology Oncology | Hematology From 2013 - 2023

Education & Training

Affiliations & Hospitals

Ratings & Reviews

Biography

Internists & Internal Medicine Doctors in Nearby Locations

Other Providers in SAN FRANCISCO, CA